Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Melanoma [Phase 1, Phase 2]

View source ↗

Summary

This trial update covers a monoclonal antibody therapy tested in patients with stage III or stage IV melanoma in Phase 1/2 trials, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Melanoma (Skin) | Phase 1, Phase 2 | Status: COMPLETED